ASRM/LinkedIn
May 18, 2026, 11:17
ASRM Responds to Supreme Court Mifepristone Decision – ASRM
American Society for Reproductive Medicine – ASRM shared a post on LinkedIn:
“While not a final decision, ASRM is pleased that the Supreme Court’s ruling will allow patients continued access to mifepristone. As the case continues to unfold, ASRM urges the Court to respect scientific evidence and FDA authority.
See Dr. Brannigan’s full statement.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 13, 2026, 15:51Why Do We Need an Early Detection Test for Ovarian Cancer? – OCRF
-
Jul 13, 2026, 15:49Christopher Robinson: Internal Manual Aortic Compression for Temporary Control of Obstetric Pelvic Hemorrhage!
-
Jul 13, 2026, 15:46Can AI Reliably Predict IVF Outcomes? – Oasis Fertility
-
Jul 13, 2026, 15:44Marco Zaccaria: EndoLatam Brings Together Latin America’s Leaders in Endometriosis Care!
-
Jul 13, 2026, 15:21Jalid Sehouli: Please, Learn from the Past…and Fight for a Better Health Care System
-
Jul 13, 2026, 15:13This Week is Birth Trauma Awareness Week – Preeclampsia Foundation
-
Jul 13, 2026, 14:51World Population Day Reminds Us That Population Trends are About More Than Numbers – CFAS
-
Jul 13, 2026, 14:34Christopher Robinson: Predictive Value of Cervical Length Measured After 24 Weeks for Spontaneous Preterm Birth
-
Jul 13, 2026, 14:17Evelyn Ndinda: What are Purposes of the 20th and 24th Week Prenatal Visits?